Clinical trials
Central Nervous System Diseases trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2010 | 1 |
| 2011 | 3 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2020 | 1 |
| 2021 | 5 |
| 2022 | 5 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Unknown status | 5 |
| Recruiting | 4 |
| Not yet recruiting | 2 |
| Enrolling by invitation | 2 |
| Terminated | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Capital Medical University | 3 |
| Bayer | 2 |
| Qianfoshan Hospital | 2 |
| Yaou Liu | 2 |
| AstraZeneca | 1 |
| Beijing Friendship Hospital | 1 |
| Changhai Hospital | 1 |
| Eisai Limited | 1 |
| Eli Lilly and Company | 1 |
| First Hospital of China Medical University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Central Nervous System Diseases | 30 |
| Brain Diseases | 17 |
| Nervous System Diseases | 16 |
| Stroke | 11 |
| Cerebrovascular Disorders | 9 |
| Vascular Diseases | 9 |
| Cardiovascular Diseases | 8 |
| Neurodegenerative Diseases | 6 |
| Alzheimer Disease | 5 |
| Brain Infarction | 5 |
Trials
Showing 76 to 30 of 30. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.